Ulcer-forming Bacteria Target Tiny Traumas

A new study finds that Helicobacter pylori home in on small lesions in the stomach and promote ulceration within minutes of epithelial injury.

Written byJyoti Madhusoodanan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Helicobacter sp.WIKIPEDIA, CDCThe ulcer-causing bacteria Helicobacter pylori swiftly swarm to sites of microscopic damage on the surface of the mouse stomach. The microbes accumulate at these injury sites within minutes, and can slow tissue repair. These are the earliest events in H. pylori pathogenesis reported in vivo, according to a study published today (July 17) in PLOS Pathogens.

Previous studies have shown that both motility and chemotaxis are crucial to H. pylori colonization in the stomach. Mutants that are unable to sense pH gradients or concentrations of chemicals such as urea, arginine, or carbon dioxide are less capable of causing ulcers, requiring several times more bacteria than wild-type strains. But how these properties helped the bacteria colonize damaged stomach tissue was not clear.

The present study “is a very nice example of how very basic bacterial properties—such as their abilities to swim or sense where they’re going—can have really important effects in disease,” said microbiologist Manuel Amieva of Stanford University who was not involved with the work. “We sometimes ignore these, because we look for disease-related factors.”

Alcohol, smoking, salt intake, and certain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies